TNFalpha antagonists in rheumatoid arthritis patients seen in everyday practice

Joint Bone Spine. 2007 Dec;74(6):523-6. doi: 10.1016/j.jbspin.2007.10.002.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Antibodies, Monoclonal / therapeutic use
  • Antirheumatic Agents / adverse effects
  • Antirheumatic Agents / therapeutic use*
  • Arthritis, Rheumatoid / drug therapy*
  • Arthritis, Rheumatoid / metabolism
  • Arthritis, Rheumatoid / physiopathology
  • Dose-Response Relationship, Drug
  • Drug Therapy, Combination
  • Etanercept
  • Humans
  • Immunoglobulin G / therapeutic use
  • Infliximab
  • Practice Guidelines as Topic
  • Receptors, Tumor Necrosis Factor / therapeutic use
  • Rheumatology*
  • Severity of Illness Index
  • Societies, Medical
  • Treatment Outcome
  • Withholding Treatment

Substances

  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Immunoglobulin G
  • Receptors, Tumor Necrosis Factor
  • Infliximab
  • Etanercept